Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588497 · ClinicalTrials.gov registry record
Characterization of the Essure System Tubal Sterilization Using Ultrasound and X-Ray
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 25
- Enrollment target
NCT00588497: Completed study, sponsored by Mayo Clinic.
NCT00588497 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588497 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Tubal sterilization is the most prevalent form of contraception in the United States and the world. Currently, approximately half of these are performed with a laparoscope and half through a mini-laparotomy after delivery. Micro-insert hysteroscopic sterilization system received FDA approval for elective sterilization in 2003. Compared to other forms of female sterilization, this procedure is minimally invasive and does not require entering the abdominal cavity. In addition, it is at least as effective in preventing pregnancy as other forms of tubal occlusion. Given the distinct advantages of this method, it could become the preferred method of tubal sterilization for physicians and their patients. Currently, there is no published data concerning the appearance of the micro-inserts system using other imaging modalities that are commonly used in gynecologic practice. As the use of this device becomes more widespread it will be more commonly encountered in radiographic imaging performed as part of routine patient care. The main objective of this study is to provide important descriptive data concerning the ultrasonographic and x-ray appearance of the micro-insert hysteroscopic sterilization device. An additional objective of this study is to identify characteristics on plain film and ultrasound (US) that correlate with tubal occlusion or patency.
Interventions
- PROCEDURE Micro-insert hysteroscopic sterilization
- RADIATION Plain abdominal Xray
- PROCEDURE Pelvic Ultrasound
- RADIATION Hysterosalpingogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-03 |
What the finished NCT00588497 record still lists
NCT00588497 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Micro-insert hysteroscopic sterilization is the first listed.
NCT00588497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00588497 about?
NCT00588497 is a clinical study titled "Characterization of the Essure System Tubal Sterilization Using Ultrasound and X-Ray". Tubal sterilization is the most prevalent form of contraception in the United States and the world. Currently, approximately half of these are performed with a laparoscope and half through a mini-laparotomy after delivery. Micro-insert hysteroscopic sterilization system received FDA approval for ele...
What is the current status of trial NCT00588497?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2004-02. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00588497?
The interventions under investigation include: Micro-insert hysteroscopic sterilization (PROCEDURE), Plain abdominal Xray (RADIATION), Pelvic Ultrasound (PROCEDURE), Hysterosalpingogram (RADIATION).
Who is sponsoring clinical trial NCT00588497?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia